Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

06 Apr 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Coronavirus Infection (COVID-19) · Enrollment 5000 · Sponsor: Duke University

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Cardiology on 06 Apr 2026. The item focuses on Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS). Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT04278404

Open Original Source More Feed Items

Related by Condition/Drug

Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failur

Cardiology • 02 Apr 2026

Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association

Research Highlights • 02 Apr 2026

Adaptations to the Chronic Disease Self-Management Program for diverse clinical and cultural populations: a scoping review protocol

Research Highlights • 18 May 2026

Feed Metadata

Source

ClinicalTrials.gov